More reports of adverse effects of implants in 2019 In 2019, the Dutch reporting centre for adverse effects of medical implants (MEBI) received 397 reports of suspected adverse effects. The reports concerned 462 implants.
Excess mortality decreasing, now also in nursing- and care homes The actual number of deaths from the novel coronavirus in the Netherlands is higher than the reported numbers that RIVM publishes daily.
COVID-19 in nursing homes It is estimated that about one-third of nursing homes in the Netherlands have at least one patient with COVID-19.
Excess mortality caused by the novel coronavirus (COVID-19) The actual number of deaths from the novel coronavirus in the Netherlands is higher than the reported numbers published by RIVM.
Regional differences in the coronavirus epidemic There are significant regional differences in the coronavirus epidemic in the Netherlands.
WHO Chemical Risk Assessment Workshop on new and emerging risks to human health from chemicals RIVM is hosting an international workshop on new and emerging risks from chemicals on 20 and 21 February 2019.
Possible health risks due to exposure to chromium-6 at tROM project Tilburg Research by RIVM shows that the participants in the so-called tROM project, their supervisors and other people involved may have been exposed to chromium-6.
Kick off European Project VITAL: Vaccines and InfecTious diseases in the Ageing popuLation Recently, the EU-sponsored Vaccines and InfecTious diseases in the Ageing popuLation (VITAL) project was launched.
Rapid developments in modern biotechnology are a challenge for risk assessment Due to developments in modern biotechnology, such as genome editing, synthetic biology and regulation of gene expression, many new applications are expected in the next ten years.
Bacteriophages: insufficient understanding of phage treatment of human infections Bacteriophages are viruses that can kill bacteria. The question is whether bacteriophages can be used to treat infections in humans.